Advertisement
Advertisement
TLSI
TriSalus Life Sciences, Inc. Common Stock
5.58
USDSponsored
-0.03
-0.53%
Aug 10, 16:00 UTC -4
Closed
After-Market
5.56
-0.02
-0.36%
TLSI Earnings Reports
Positive Surprise Ratio
TLSI beat 4 of 11 last estimates.
36%
Next Report
Date of Next Report
Nov 16, 2026
Estimate for Q3 26 (Revenue/ EPS)
$14.91M
/-$0.10
Implied change from Q2 26 (Revenue/ EPS)
+30.66%
/-37.50%
Implied change from Q3 25 (Revenue/ EPS)
+28.89%
/-60.00%
TriSalus Life Sciences, Inc. Common Stock earnings per share and revenue
On Aug 06, 2026, TLSI reported earnings of -0.16 USD per share (EPS) for Q2 26, missing the estimate of -0.15 USD, resulting in a -1.20% surprise. Revenue reached 11.41 million, compared to an expected 10.47 million, with a 8.95% difference. The market reacted with a +15.20% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 14.91 million USD, implying an decrease of -37.50% EPS, and increase of 30.66% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
CeriBell, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.48
Actual
-$0.51
Surprise
-6.10%
Varex Imaging Corporation Common Stock
Report Date
Aug 10, 2026 For Q3 26
Estimate
$0.21
Actual
$0.31
Surprise
+44.93%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
Village Farms International, Inc. Common Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.02
Actual
$0.06
Surprise
+154.24%
Accendra Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.19
Surprise
-113.00%
Quanterix Corporation Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.46
Actual
-$0.45
Surprise
+4.09%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
Veru Inc.
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.30
Surprise
+8.09%
FAQ
What were TriSalus Life Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, TriSalus Life Sciences, Inc. Common Stock reported EPS of -$0.16, missing estimates by -1.2%, and revenue of $11.41M, 8.95% above expectations.
How did the market react to TriSalus Life Sciences, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 15.2%, changed from $4.87 before the earnings release to $5.61 the day after.
When is TriSalus Life Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 16, 2026.
What are the forecasts for TriSalus Life Sciences, Inc. Common Stock's next earnings report?
Based on 8
analysts, TriSalus Life Sciences, Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $14.91M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement